Specifically, we quantified an average of 1703 proteins in the Aβ+/tau + group, 1614 in the Aβ+/tau- and 1694 in the non-AD control group (Fig. 1B, supplemental Tables S1, and S2). The gene discussed is MAPT; the disease is Alzheimer disease.